Compounded or Brand-Name GLP-1? Making Sense of It in 2026
If you’ve seen compounded semaglutide for a fraction of the brand-name price and wondered whether it’s safe, legitimate, or even still allowed, you’re asking exactly the right questions. The landscape shifted this past year, so let’s sort out what changed, what each option really costs, and how to choose without second-guessing yourself later.
Here’s the big shift: the FDA now considers the semaglutide shortage resolved. That matters because the shortage was what made widespread compounding allowable in the first place. With it lifted, that legal footing has narrowed, and warning letters have gone out to a number of compounding pharmacies. None of this means compounded medication is off-limits — it means doing a little homework on any program you’re considering is more important than ever.
What “compounded” actually means
When a medication is compounded, a licensed pharmacy mixes it to order rather than dispensing a sealed, mass-manufactured product. Brand-name GLP-1s like Wegovy and Zepbound go through the FDA’s full approval process — every batch is made and tested to a tightly controlled standard. Compounded versions skip that specific review, which is why they can be so much cheaper, and also why the source matters so much. A reputable, state-licensed pharmacy can produce a careful, consistent product; a sloppy one can’t. The label “compounded” alone doesn’t tell you which you’re getting.
What you’ll pay
| Option | Monthly cost | FDA approved | Legal status |
|---|---|---|---|
| Brand-name injectable | $900–$1,350/mo | Fully legal | |
| Compounded injectable | $149–$499/mo | Legal basis narrowed | |
| Oral semaglutide tablet | $149/mo (lowest dose) | Fully legal |
Seed data — please verify current prices and legal status before relying on them.
How to decide which is right for you
Start with coverage. If your insurance helps pay for a brand-name GLP-1, that’s usually the most reassuring path — you get an FDA-reviewed medication, often at a price that rivals or beats compounding once your plan kicks in. If you’re paying entirely out of pocket, the math changes, and a verified compounded program or an oral semaglutide tablet can make treatment possible when the brand-name list price simply isn’t. The goal isn’t to chase the lowest number; it’s to find the safest option you can realistically afford and stay on.
Where we land
When you can swing it, we lean toward FDA-approved medications — the extra oversight is worth a lot for something you’ll take for months. So if you’re insured, ask your provider about brand-name coverage before assuming it’s out of reach. Paying cash? An oral semaglutide tablet is often the most affordable legitimate option, and if you’re Medicare-eligible, it’s well worth checking the new GLP-1 Bridge program before you settle on anything.
Frequently Asked Questions
Related Resources
Our 2026 Program Rankings
See how all six programs stack up, side by side.
Compounded or Brand-Name?
What the end of the semaglutide shortage means for you.
Medicare GLP-1 Coverage
From July 2026, Medicare covers GLP-1 at $50 a month.
Handling Side Effects
Friendly tips for getting through the common GLP-1 side effects.
Find Your Match
A two-minute quiz to point you toward the right fit.
The Most Affordable Programs
Compare the options by what you'd actually pay.
Not sure which program is the right fit?
Answer six quick questions and we'll point you to the programs that suit your budget, your insurance, and how you want to be cared for.